1heals / iStockphoto.com

9 May 2018Big Pharma

HGF opens life sciences-led office in Ireland, before Brexit

HGF has opened its 16th office—in Westport, Ireland—in an effort to capitalise on investments in the life sciences sector and ensure the firm is well positioned for Brexit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

HGF hires former Roivant Sciences VP

5 November 2018 HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

HGF adds IP partner in The Hague office

22 January 2019 Law firm HGF has added Leythem Wall as a partner.

Pressure on Ireland to back COVID vaccine IP waiver

12 March 2021 Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.

More on this story

HGF hires former Roivant Sciences VP

5 November 2018 HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

HGF adds IP partner in The Hague office

22 January 2019 Law firm HGF has added Leythem Wall as a partner.

Pressure on Ireland to back COVID vaccine IP waiver

12 March 2021 Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.

More on this story

HGF hires former Roivant Sciences VP

5 November 2018 HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.

HGF adds IP partner in The Hague office

22 January 2019 Law firm HGF has added Leythem Wall as a partner.

Pressure on Ireland to back COVID vaccine IP waiver

12 March 2021 Ireland is the latest country to come under pressure to back the World Trade Organisation’s appeal to waive intellectual property rights related to COVID-19 vaccines, as developing countries struggle to vaccinate their populace.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent